-
CVS Health announces results of solid Q3
For the third quarter ended Sept. 30, CVS Health reported $38.6 billion in net revenues, representing an increase of 10.3%. Revenues across the Pharmacy Services Segment increased 13.3% to $25.5 billion, primarily driven by growth in specialty pharmacy and pharmacy network claims.
“We delivered solid revenue and operating profit growth across our businesses, and we continue to expect significant growth in the fourth quarter, rounding out another terrific year for our company,” Larry Merlo, CVS Health president and CEO, said. -
Report: Walgreens-Rite Aid deal likely to avoid antitrust issues
Despite concern from smaller pharmacies, Walgreens’ plan to acquire Rite Aid is likely to be approved by the FTC, according to a report by International Business Times. “The location strategies of these two companies have been historically quite different,” said Howard Davidowitz, a New York-based retail consultant.

